199 related articles for article (PubMed ID: 26659251)
1. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.
Welker AM; Jaros BD; Puduvalli VK; Imitola J; Kaur B; Beattie CE
Dis Model Mech; 2016 Feb; 9(2):199-210. PubMed ID: 26659251
[TBL] [Abstract][Full Text] [Related]
2. Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma.
Welker AM; Jaros BD; An M; Beattie CE
Neuroscience; 2017 Jul; 356():35-43. PubMed ID: 28526577
[TBL] [Abstract][Full Text] [Related]
3. NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.
Flüh C; Chitadze G; Adamski V; Hattermann K; Synowitz M; Kabelitz D; Held-Feindt J
Histochem Cell Biol; 2018 Mar; 149(3):219-233. PubMed ID: 29356965
[TBL] [Abstract][Full Text] [Related]
4. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
Wang W; Cho HY; Rosenstein-Sisson R; Marín Ramos NI; Price R; Hurth K; Schönthal AH; Hofman FM; Chen TC
J Neurosurg; 2018 Mar; 128(3):695-700. PubMed ID: 28409734
[TBL] [Abstract][Full Text] [Related]
6. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
[TBL] [Abstract][Full Text] [Related]
7. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.
Lu J; Zhuang Z; Song DK; Mehta GU; Ikejiri B; Mushlin H; Park DM; Lonser RR
J Neurosurg; 2010 Aug; 113(2):225-33. PubMed ID: 20001590
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
9. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
10. Induction of neural differentiation in rat C6 glioma cells with taxol.
Chao CC; Kan D; Lo TH; Lu KS; Chien CL
Brain Behav; 2015 Dec; 5(12):e00414. PubMed ID: 26665000
[TBL] [Abstract][Full Text] [Related]
11. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
12. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
13. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Jiang Y; Marinescu VD; Xie Y; Jarvius M; Maturi NP; Haglund C; Olofsson S; Lindberg N; Olofsson T; Leijonmarck C; Hesselager G; Alafuzoff I; Fryknäs M; Larsson R; Nelander S; Uhrbom L
Cell Rep; 2017 Jan; 18(4):977-990. PubMed ID: 28122246
[TBL] [Abstract][Full Text] [Related]
15. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
17. Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.
Kratzsch T; Kuhn SA; Joedicke A; Hanisch UK; Vajkoczy P; Hoffmann J; Fichtner I
J Cancer Res Clin Oncol; 2018 May; 144(5):809-819. PubMed ID: 29427211
[TBL] [Abstract][Full Text] [Related]
18. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
19. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ
BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.
Kang MK; Kang SK
Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
